Clinical trial

24-hour Intraocular Pressure (IOP) Control With the Bimatoprost/Timolol Fixed…

NCT00486486 · Aristotle University Of Thessaloniki, Other · Completed

Key facts

NCT number NCT00486486
Title 24-hour Intraocular Pressure (IOP) Control With the Bimatoprost/Timolol Fixed Combination
Official title A 3-month, 4-centre, Crossover, Double-masked Study Investigating the 24-hour Intraocular Pressure Control With the Bimatoprost/Timolol Fixed Combination Dosed Morning, or Evening in Subjects With Exfoliative Glaucoma
Acronym BTFC
Lead sponsor Aristotle University Of Thessaloniki, Other
Status Completed
Phase Phase 4
Study type Interventional
Conditions Glaucoma
Intervention type Drug
Interventions Drug: bimatoprost/timolol fixed combination AM, Bimatoprost/timolol fixed combination dosed PM
Enrollment 60
Start date Mar 1, 2007
Primary completion May 1, 2008
Completion Jul 1, 2008
First posted Jun 14, 2007
Last update posted May 12, 2014
Countries Greece

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies